一份國(guó)際性的同行評(píng)審期刊，聚焦于所有癌癥的病理基礎(chǔ)、治療的潛在目標(biāo)和用于改善癌癥患者管理的治療方案。該雜志還關(guān)注管理方案、新的治療劑和治療方案對(duì)患者生活質(zhì)量、依從性和滿意度等方面的影響。這本雜志探討了新療法和現(xiàn)有療法在改善結(jié)果方面的證據(jù)，并且，重要的是，將尋求根據(jù)患者和醫(yī)療保健專(zhuān)業(yè)人員的最終吸收和接受來(lái)定義它們的用法。

An international, peer-reviewed journal focusing on the pathological basis of all cancers, potential targets for therapy and treatment protocols employed to improve the management of cancer patients. The journal also focuses on the impact of management programs and new therapeutic agents and protocols on patient perspectives such as quality of life, adherence and satisfaction. This journal explores the evidence behind new and existing therapies in terms of improving outcomes and, importantly, will seek to define their usage in terms of ultimate uptake and acceptance by the patient and health care professional.